Michael Cimorelli is a Ph.D. candidate in the Chemical and Biological Engineering Department studying under the advisement of Dr. Steven Wrenn. The broader strokes of his research focus on the development of the next generation ultrasound enhancing agent that is engineered for quantifying myocardial perfusion, monitoring ischemia, and detecting infarction. As a Ph.D. candidate in the Wrenn Lab, he specializes in medical imaging techniques, surface force interactions, and developing and characterizing lab-derived vesicles. Through Fulbright, he hopes to take his skill set that he’s honed in the Wrenn Lab and translate it to a new problem – developing a biomarker for kidney cancer from liquid biopsy by using Surface Plasmon Resonance Imaging under the guidance of Dr. Rienk Nieuwland at the University of Amsterdam’s Academic Medical College. Upon completion of his Fulbright, Michael plans to pursue a career dedicated to helping those with life-threatening medical conditions by bridging the gap between medicine and science through effective collaboration between academia and industry partners.
Last updated: March 2019